• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Revolutions Medical Signs Contract for Rev Vac Manufacturing Service With Strategic Product Development, Inc.

Posted on: Thursday, 11 September 2008, 12:00 CDT

Revolutions Medical Corp (OTCBB: RMCP) signs contract with Strategic Product Development, Inc to move forward with secure manufacturing for its proprietary Rev Vac safety syringe.

"Strategic Product Development, Inc, SPD, is pleased to have reached an agreement with RevMed to source manufacturing for the Rev Vac safety syringe family. We will use our extensive expertise with off-shore and domestic high volume manufacturing to assess and secure the appropriate facility for the manufacture of the Rev Vac safety syringe. SPD is pleased to work with this unique vacuum technology. With our expertise Revolutions Medical will have access to a low cost high quality manufacturing solution ensuring price, quality and performance competitive advantages," reported Richard Theriault, President of SPD.

About Strategic Product Development, Inc

It provides design, development and manufacturing management services to the high technology sector. SPD has resources, on the ground in China and Taiwan, to assess and manage low cost, high quality manufacturing resources for its clients.

About Revolutions Medical Corporation

Revolutions Medical Corporation is committed to continually developing and distributing new products and tools to the medical industry, whether internally or through acquisitions. Its goals are to make health care safer and less expensive by reducing risks and cutting time and expenses. Its products include the Rev Vac safety syringe, safety blood drawing device and safety IV catheter. The world market for safety-engineered medical devices (SEMDs) is projected to exceed 2 billion this year and is forecasted to maintain a 20% annual growth rate in the near term. Revolutions Medical also provides software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software includes sorting of images, color, 3D, and automatic segmentation of images. These tools will enhance the physician's diagnostic confidence in an industry that is growing at 10% - 15% (more than 25 million procedures) per year with a worldwide market potential for these tools that exceeds $3.5 billion.

Safe Harbor

Forward-looking statements made in this release are made pursuant to the "safe-harbor" provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Revolutions Medical Corporation are not a guarantee of future performance. This news release includes forward- looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty.

Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Revolutions Medical Corporation, and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition.

Source: Business Wire

More News in this Category